Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?

Authors

  • Hasan M. Shihab Infectious Diseases Institute, Makerere University, Kampala
  • Fred Lutwama Infectious Diseases Institute, Makerere University, Kampala
  • Theresa Piloya Infectious Diseases Institute, Makerere University, Kampala
  • Barbara Castelnuovo Infectious Diseases Institute, Makerere University, Kampala
  • Andrew D. Kambugu Infectious Diseases Institute, Makerere University, Kampala
  • Robert Colebunders Infectious Diseases Institute, Makerere University, Kampala

DOI:

https://doi.org/10.3855/jidc.251

Keywords:

edema, Lopinavir/Ritonavir, resource-limited setting

Abstract

A large number of patients are switched to second-line antiretroviral therapy, especially in resource limited settings. Lopinavir/Ritonavir is the main drug used in second-line treatment regimens. We describe a patient attending an HIV treatment centre in Kampala, Uganda, who presented with bilateral non-tender pitting inflammatory edema two weeks after switching to a Lopinavir/Ritonavir-containing second-line treatment regimen. The lack of an alternate explanation led us to suspect that Lopinavir/Ritonavir was potentially responsible for the edema.

Downloads

Published

2009-06-01

How to Cite

1.
Shihab HM, Lutwama F, Piloya T, Castelnuovo B, Kambugu AD, Colebunders R (2009) Bilateral pedal edema in an HIV patient: Lopinavir/Ritonavir-containing treatment regimen as a potential cause?. J Infect Dev Ctries 3:405–407. doi: 10.3855/jidc.251

Issue

Section

Case Reports